146 filings
8-K
RZLT
Rezolute Inc
15 May 24
Rezolute Reports Third Quarter Fiscal 2024 Financial Results and Provides Business Update
4:13pm
8-K
RZLT
Rezolute Inc
25 Apr 24
Phase 2 RIZE Study Sub-Analyses to be Presented at the 2024 Pediatric Endocrine Society Annual Meeting
5:23pm
8-K
RZLT
Rezolute Inc
14 Mar 24
Entry into a Material Definitive Agreement
5:00pm
8-K
RZLT
Rezolute Inc
11 Mar 24
Regulation FD Disclosure
5:03pm
8-K
RZLT
Rezolute Inc
22 Feb 24
Other Events
5:00pm
8-K
5mm1un74
13 Feb 24
Rezolute Reports Second Quarter Fiscal 2024 Results and Provides Business Update
4:10pm
8-K
iq4zgp xj73x8u
29 Jan 24
Unregistered Sales of Equity Securities
5:15pm
8-K
80b7ed s6z8h2
14 Dec 23
Plans to report topline data mid-second quarter 2024
4:01pm
8-K
fzc311ktc hm9yettrc
22 Nov 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:35pm
8-K
ma89jo
13 Nov 23
Rezolute Reports First Quarter Fiscal 2024 Results
4:13pm
8-K
uqp2 jpf4hdyn
18 Oct 23
PRIME eligibility granted based on key positive data from the Phase 2b (RIZE) study and current unmet medical need in congenital hyperinsulinism
4:30pm
8-K
swig780g
13 Oct 23
Rezolute Announces Further Evidence of RZ358’s Efficacy in Tumor-Mediated Hyperinsulinism
4:47pm
8-K
ig8naxb
14 Sep 23
Rezolute Reports Full Year Fiscal 2023 Results and Highlights Company Progress
4:10pm
8-K
w3ltf3tvwjn9hux7
27 Jun 23
Study to be initiated in Europe and other ex-US geographies in Q4 2023, with topline results expected 1H 2025
4:06pm
8-K
tytv 6nvrm6a
20 Jun 23
Regulation FD Disclosure
6:55am
8-K
hzj3rqg7l6a
2 Jun 23
Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
4:30pm
8-K
e6bbz0t
26 May 23
Submission of Matters to a Vote of Security Holders
12:00am
8-K
4r957kv725cqgm9ij
11 May 23
Rezolute Reports Third Quarter Fiscal 2023 Results and Highlights Company Progress
4:15pm
8-K
slgji78k7r7 wfymk
10 Feb 23
Rezolute Reports Second Quarter Fiscal 2023 Results and Highlights Company Progress
4:10pm
8-K
80lotlelw
13 Jan 23
Departure of Directors or Certain Officers
4:16pm